Edwards Lifesciences CorpNYSE:EW
- LAST PRICE71.0450
- TODAY'S CHANGE (%)-1.0250 (-1.4222%)
- Bid / Lots71.0200/ 2
- Ask / Lots71.0500/ 6
- Open / Previous Close71.5700 / 72.0700
- Day Range
- 52 Week Range
- Volume859,400
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | EW |
|---|---|---|
| 09:32 ET | 56574 | 71.34 |
| 09:33 ET | 11459 | 71.28 |
| 09:35 ET | 25348 | 71.05 |
| 09:37 ET | 24772 | 70.56 |
| 09:39 ET | 19927 | 70.995 |
| 09:42 ET | 27475 | 71 |
| 09:44 ET | 11872 | 71.125 |
| 09:46 ET | 75443 | 70.6175 |
| 09:48 ET | 7431 | 70.605 |
| 09:50 ET | 65293 | 70.54 |
| 09:51 ET | 12300 | 70.98 |
| 09:53 ET | 6810 | 70.98 |
| 09:55 ET | 3783 | 70.99 |
| 09:57 ET | 4700 | 71.14 |
| 10:00 ET | 11353 | 71.105 |
| 10:02 ET | 2829 | 71.11 |
| 10:04 ET | 6943 | 71.16 |
| 10:06 ET | 14192 | 71.3 |
| 10:08 ET | 6432 | 71.295 |
| 10:09 ET | 4102 | 71.205 |
| 10:11 ET | 6973 | 71.2 |
| 10:13 ET | 13020 | 71.235 |
| 10:15 ET | 2372 | 71.28 |
| 10:18 ET | 3596 | 71.315 |
| 10:20 ET | 2123 | 71.26 |
| 10:22 ET | 1740 | 71.2 |
| 10:24 ET | 3565 | 71.19 |
| 10:26 ET | 4059 | 71.2 |
| 10:27 ET | 4860 | 71.14 |
| 10:29 ET | 5611 | 71.11 |
| 10:31 ET | 1900 | 71.0725 |
| 10:33 ET | 9849 | 71.08 |
| 10:36 ET | 3468 | 71.115 |
| 10:38 ET | 7102 | 71.145 |
| 10:40 ET | 5942 | 71.17 |
| 10:42 ET | 1283 | 71.17 |
| 10:44 ET | 8223 | 71.125 |
| 10:45 ET | 6312 | 70.95 |
| 10:47 ET | 4622 | 70.91 |
| 10:49 ET | 5945 | 70.95 |
| 10:51 ET | 3955 | 70.99 |
| 10:54 ET | 2815 | 70.94 |
| 10:56 ET | 1914 | 70.89 |
| 10:58 ET | 5737 | 70.86 |
| 11:00 ET | 7221 | 70.78 |
| 11:02 ET | 5735 | 70.82 |
| 11:03 ET | 5466 | 70.745 |
| 11:05 ET | 7755 | 70.765 |
| 11:07 ET | 1079 | 70.74 |
| 11:09 ET | 5765 | 70.73 |
| 11:12 ET | 3320 | 70.8199 |
| 11:14 ET | 6074 | 70.81 |
| 11:16 ET | 3341 | 70.83 |
| 11:18 ET | 2301 | 70.94 |
| 11:20 ET | 4684 | 70.99 |
| 11:21 ET | 2616 | 70.94 |
| 11:23 ET | 4870 | 70.87 |
| 11:25 ET | 2628 | 70.89 |
| 11:27 ET | 4551 | 70.875 |
| 11:30 ET | 4453 | 70.97 |
| 11:32 ET | 3590 | 71.03 |
| 11:34 ET | 2826 | 71.01 |
| 11:36 ET | 6600 | 71.06 |
| 11:38 ET | 7563 | 71.02 |
| 11:39 ET | 2070 | 71.045 |
| 11:41 ET | 4395 | 71.06 |
| 11:43 ET | 1265 | 71.045 |
Today
Investors With Losses Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against Edwards Lifesciences Corporation, from 42 minutes ago by Dow Jones
42 minutes ago by Dow JonesLevi & Korsinsky Notifies Edwards Lifesciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - EW, from 55 minutes ago by Dow Jones
55 minutes ago by Dow JonesEdwards Lifesciences Corporation (EW) Investors: December 13, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP, from 1 hour ago by Dow Jones
1 hour ago by Dow JonesEW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm, from 1 hour ago by Dow Jones
1 hour ago by Dow JonesLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lifesciences Corporation Lawsuit - EW, from 3 hours ago by Dow Jones
3 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Edwards Lifesciences Corp | 42.5B | 30.0x | +14.85% |
Agilent Technologies Inc | 39.4B | 43.0x | --- |
Resmed Inc | 36.6B | 33.1x | +19.48% |
Veeva Systems Inc | 36.7B | 59.4x | +17.29% |
Illumina Inc | 22.7B | -14.4x | --- |
Hologic Inc | 18.0B | 23.9x | --- |
Company Information
Edwards Lifesciences Corporation is a global structural heart innovation company. The Company is engaged in patient-focused medical innovations for structural heart disease and invests in research and development to transform care for those impacted by structural heart disease. Its products are categorized into groups, including Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart (Surgical). It develops transcatheter heart valve replacement technologies designed for the minimally invasive replacement of aortic heart valves. The Edwards SAPIEN family of valves includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra, and the Edwards SAPIEN 3 Ultra RESILIA systems, are catheter-based approaches for treating severe symptomatic aortic stenosis. Its PASCAL PRECISION and Cardioband transcatheter valve repair systems are commercially available in Europe for mitral and tricuspid valve repair.
Contact Information
- Headquarters
- One Edwards WayIRVINE, CA, United States 92614
- Phone
- 949-250-2500
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Nicholas Valeriani
- President, Chief Executive Officer
- Bernard Zovighian
- Chief Financial Officer, Corporate Vice President
- Scott Ullem
- Senior Vice President, General Manager - Surgical Structural Heart
- Wayne Markowitz
- Corporate Vice President - Strategy and Corporate Development
- Donald Bobo
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $42.5B |
|---|---|
Revenue (TTM) | $5.6B |
Shares Outstanding | 589.8M |
Edwards Lifesciences Corp does not pay a dividend. | |
Beta | 1.13 |
EPS | $2.37 |
Book Value | $11.06 |
P/E Ratio | 30.0x |
Price/Sales (TTM) | 7.6 |
Price/Cash Flow (TTM) | 27.2x |
Operating Margin | 26.17% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
